Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-24 Purchase |
2021-09-28 5:48 pm |
LEAP THERAPEUTICS INC. | LPTX | BeiGene Ltd. 10% Owner |
2,543,800 | $2.85 | $7,249,830 | 7,348,437 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-16 6:06 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
347,803 | $28.82 | $10,022,365 | 47,814,827 (Indirect Direct) |
View |
| 2021-08-31 Sale |
2021-09-02 8:40 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
204,358 | $24.09 | $4,922,921 | 47,814,827 (Indirect Direct) |
View |
| 2021-08-04 Sale |
2021-08-05 9:03 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
83,200 | $25.97 | $2,160,781 | 47,814,827 (Indirect Direct) |
View |
| 2021-08-03 Sale |
2021-08-05 9:01 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
41,400 | $25.17 | $1,041,881 | 47,814,827 (Indirect Direct) |
View |
| 2021-07-22 Sale |
2021-07-22 6:23 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
57,900 | $23.71 | $1,373,070 | 47,814,827 (Indirect Direct) |
View |
| 2021-07-20 Sale |
2021-07-22 6:21 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
39,600 | $24.6 | $974,108 | 47,814,827 (Indirect Direct) |
View |
| 2021-07-08 Sale |
2021-07-08 7:11 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
51,300 | $24.24 | $1,243,717 | 47,814,827 (Indirect Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 7:09 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
85,000 | $25.29 | $2,149,295 | 47,815,127 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 5:12 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
61,750 | $0 | 143,299 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:10 pm |
N/A 2032-02-27 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
22,581 | $0 | 22,581 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 5:07 pm |
N/A 2032-02-27 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
22,581 | $0 | 22,581 (Direct) |
View |
| 2021-09-28 Gift |
2021-12-17 5:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
116,376 | $0 | 174,551 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:05 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
0 | $30.13 | 174,551 (Indirect) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
0 | $30.13 | 968,261 (Indirect) |
View |
| 2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 371,331 (Direct) |
View |
| 2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 371,331 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 6:21 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,869 | $0 | 0 (Direct) |
View |
| 2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 376,011 (Direct) |
View |
| 2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 376,011 (Direct) |
View |
| 2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 395,511 (Direct) |
View |
| 2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 395,511 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
6,000 | $119.96 | 415,011 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
78,000 | $0 | 415,011 (Direct) |
View |
| 2021-08-31 Option Award |
2021-09-02 8:39 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,374 | $0 | 0 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
5,255 | $174.43 | 974,206 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
6,914 | $160.4 | 974,206 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
8,831 | $119.96 | 974,206 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
273,000 | $0 | 974,206 (Direct) |
View |
Ownership |
2021-07-01 4:55 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
0 | $0 | 366,483 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 506,236 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 506,236 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-24 12:26 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:57 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,053,156 | $0 | 55,658,639 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:50 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
280,839 | $0 | 11,699,072 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:49 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
561,678 | $0 | 500,043 (Direct) |
View |